Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2026 Aug 26;17:1844013. doi: 10.3389/fphar.2026.1844013

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2026 Chen, Han, Zhang, Cao and Wang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Panel A shows a Venn diagram comparing gene counts between Genecards and OMIM, with 3,929 genes overlapping. Panel B depicts a four-set Venn diagram of genes targeted by lapatinib, neratinib, trastuzumab, and tucatinib with intersections labeled. Panel C presents a Venn diagram contrasting genes related to drugs and to phenotype, with 14 overlapping genes. Panel D is a network diagram showing interactions among gene products, with central hubs labeled. Panel E shows a bipartite network linking drugs and genes, with lines indicating associations. — (A) Venn diagram of GeneCards and OMIM databases in tumor progression. (B) Venn diagram of four drugs. (C) Venn diagram of drugs and targets of tumor progression. (D) Protein-protein interaction network of common targets. (E) The network of Drug-Target-Pathway network.